USFDA accepts Wockhardt’s NDA for breakthrough antibiotic Zaynich
[ad_1] The United States Food and Drugs Administration (USFDA) has formally accepted Wockhardt Ltd’s New Drug Application (NDA) for its breakthrough antibiotic Zaynich, the Indian drug maker said in a statement. This is the first time ever that an NDA from a new chemical entity (NCE) from an Indian pharma company has been filed and…